We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

65 hedge funds and large institutions have $509M invested in Q32 Bio in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 4

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

92% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 12

30% more funds holding

Funds holding: 50 → 65 (+15)

12% more capital invested

Capital invested by funds: $455M → $509M (+$53M)

0.4% more ownership

Funds ownership: 2.97% → 3.37% (+0.4%)

Holders
65
Holders Change
+15
Holders Change %
+30%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
19
Increased
23
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$25.2M
2
BlackRock
BlackRock
New York
+$17.6M
3
State Street
State Street
Massachusetts
+$2.63M
4
PC
Polar Capital
United Kingdom
+$2.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.6M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.08M
2
MC
Maverick Capital
Texas
-$3.8M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$3.28M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$2.06M
5
SFM
Sphera Funds Management
Israel
-$1.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
EIM
51
Essex Investment Management
Massachusetts
$169K +$159K +421 New
Barclays
52
Barclays
United Kingdom
$145K +$54.5K +144 +66%
MLICM
53
Metropolitan Life Insurance Company (MetLife)
New York
$138K +$130K +343 New
Citigroup
54
Citigroup
New York
$93K +$30.3K +80 +53%
PCM
55
Prelude Capital Management
New York
$93K +$87.7K +232 New
Legal & General Group
56
Legal & General Group
United Kingdom
$71K +$33.7K +89 +103%
Canada Life
57
Canada Life
Manitoba, Canada
$56K +$54.1K +143 New
UBS Group
58
UBS Group
Switzerland
$25K -$39.7K -105 -63%
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
$22K -$9.08K -24 -30%
AG
60
Advisor Group
Arizona
$22K +$21.2K +56 New
AIP
61
Ameritas Investment Partners
Nebraska
$19K – – –
Daiwa Securities Group
62
Daiwa Securities Group
Japan
$8K +$7.18K +19 New
Bank of Montreal
63
Bank of Montreal
Ontario, Canada
$5K +$3.4K +9 +225%
MAM
64
Meeder Asset Management
Ohio
$5K +$5.29K +14 New
Federated Hermes
65
Federated Hermes
Pennsylvania
$3K -$378 -1 -13%
MC
66
Maverick Capital
Texas
– -$3.8M -9,236 Closed
SAM
67
Sectoral Asset Management
Quebec, Canada
– -$3.28M -7,972 Closed
HLA
68
Hamilton Lane Advisors
Pennsylvania
– -$2K -5,634 Closed
BNP Paribas Financial Markets
69
BNP Paribas Financial Markets
France
– -$7.82K -19 Closed
1 2
3

QTTB Hedge Fund Activity: Q4 2018 in Review

65 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2018, worth a combined $509M — up 12% from $455M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new QTTB positions and 4 closed out — a net gain of 15 holders — while 23 added to existing stakes and 12 trimmed.

The largest buyer was RTW Investments, adding an estimated $25.2M. The largest seller was Fidelity Investments, cutting an estimated $5.08M.

  • 65 institutional investors held Q32 Bio (QTTB) as of Q4 2018, up from 50 in Q3 2018.
  • Funds reported $509M of Q32 Bio stock for Q4 2018, up 12% quarter-over-quarter.
  • 19 funds opened new Q32 Bio positions in Q4 2018 and 4 closed out, a net change of +15 holders.
  • The largest Q32 Bio buyer in Q4 2018 was RTW Investments, an estimated $25.2M added.
  • The largest Q32 Bio seller in Q4 2018 was Fidelity Investments, an estimated $5.08M sold.

Based on aggregated 13F filings for Q4 2018.